Replies to post #66100 on Avid Bioservices Inc (CDMO)

[Frustrated]

The potential for the stock price to soar was there. Unfortunately we were let down again.

http://www.thestreet.com/_yahoo/story/11182038/1/5-earnings-stocks-that-could-explode.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA

From the article:

Market players are going to want to watch what PPHM's management has to say about Phase II survival data for its treatment of non-small cell lung cancer. Any positive comments on the conference call could send the stock soaring

I guess today's stock price tells it all about what they thought of the conference call.

[Green grine]

You definitely heard a different cc than I did yesterday. Did you miss the part where he talked about the new customers buying from Avid? Avid is not "just sitting there".

Personally, I am invested in this company for reasons other than Avid - Avid just complements Peregrine.

Frustrating that trials don't go faster than they do? Yes. I'm looking forward to the likely Cotara partnership(s) later this year or next spring and hope for continued positive progress with the Bavi trials. I am quite sure that these top-notch scientists are being hired for good reason, and I'm sure Garnick and others have provided input on all of these recent hires of former Genentech employees with experience getting drugs approved.

Institutional ownership is higher than I can remember it being in the past 10 years. Are there games being played with stock price? Absolutely. It will continue until we (fingers crossed) do a Cotara deal.

Green